- When did Noxopharm become a publicly-listed company?
The Company listed on the Australian Securities Exchange in August 2016.
- Who manages the Share Register (Transfer Agent)?
Automic Group Registry Services is Noxopharm Limited's share registry and administers all matters relating to shares directly registered with the company. To login and access your shareholding please visit https://www.automicgroup.com.au/
- How can I buy and sell company shares?
All company shares currently are traded on the ASX and can be bought or sold through a licensed stockbroker. The process of buying or selling shares is explained on the ASX website, please go to https://www.asx.com.au/products/shares/buying-selling-shares.htm
- How can I obtain an Annual Report?
All annual reports are available on our website through this link
- How can I follow the Company's share price activity?
Current share prices are available on the ASX website www.asx.com.au and can be searched using the Company's ASX ticker symbol: NOX
- Does Noxopharm have any independent research coverage?
Yes, research coverage can be found in the Investors sections
- What is the ASX ticker code?
The ASX ticker code for the Company is ASX: NOX.
- Where do I find information about my shareholding?
The share register is managed by Automic Registry Services. The registry provides a number of services which can be accessed online. https://www.automicgroup.com.au/
When accessing some information online you may be required to enter your Security Reference Number (SRN) or Holder Identification Number (HIN) as shown on your Issuer Sponsored/CHESS statements and other personal details such as your postcode. Please visit the Glossary for more information.
- Where can I find the latest financial information?
The latest financial reports can be found Noxopharm Financial reports
- What is the Company's financial year end?
The Company's end of financial year is the 30th of June.
- When will the AGM be held?
An Australian listed company is required to hold its annual general meeting within five months of its financial year end. Accordingly shareholders will be notified in the months of September or October, approximately 28 days in advance of when and where the AGM will be held. Typically, Noxopharm holds its AGM in mid-late November each year.
- Who are the auditors?
The Company’s auditors are William Buck Audit Pty Ltd, L 20, 181 William St, Melbourne. VIC 3000
- Where can I find the Corporate Governance Policy?
Our Corporate Governance policy can be found here: Noxopharm Corporate Governance Policy. This includes our Board Charter, Code of Conduct, Diversity Policy, Continuous Disclosure Policy, Shareholder Communication Policy, Risk Management Policy and our Securities Trading Policy.
- What is the dividend policy?
The Company does not currently have a dividend policy in place. It is the Company’s intention to fully commercialise its drug candidates through a number of potential avenues, and to reinvest any future profits in order to grow the business. The Board reviews its growth strategy and potential commercial opportunities at regular meetings and assesses them against the Company’s working capital requirements and growth opportunities.
- How can I request additional information?
Please email firstname.lastname@example.org requesting additional information
- What is the Company’s mailing address?
PO BOX 292 Gordon 2072, NSW AUSTRALIA
- Who is the Company Secretary?
Australian Securities Exchange (ASX) = Australia’s primary securities exchange. It is sometimes referred to outside Australia as the Sydney Stock Exchange.
Australian Securities and Investments Commission (ASIC) = an independent Australian government body that acts as Australia’s corporate regulator.
The Therapeutic Goods Administration (TGA) = the regulatory body that governs therapeutic goods in Australia.
Investigational New Drug (IND) Application = a request for authorization from the U.S. Food and Drug Administration (FDA) to start human clinical trials and to ship an experimental drug across state lines.
Orphan Drug Designation (ODD) = a status granted by the FDA or EMA to a pharmaceutical agent developed to treat a rare medical condition.
European Medicines Agency (EMA) = the regulatory body that oversees evaluation of medicinal products throughout Europe.
The Food and Drug Administration (FDA) = a federal agency of the United States Department of Health and Human Services responsible for protecting public health through the control and supervision of specific products, including pharmaceuticals.
Holder Identification Number (HIN) = a unique number that is issued to you by ASX when you become a client of a broker under which all of an individual’s holdings are consolidated.
Annual General Meeting (AGM) = the yearly meeting of a general organization or membership.
Shareholder Reference Number (SRN) = used to identify shares that you own in a company. A different SRN is issued for each company you own shares in. You can find your SRN number on a holding statement mailed by the company’s shared registry to you.